Literature DB >> 15479788

Mechanisms of human papillomavirus-induced oncogenesis.

Karl Münger1, Amy Baldwin, Kirsten M Edwards, Hiroyuki Hayakawa, Christine L Nguyen, Michael Owens, Miranda Grace, Kyungwon Huh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15479788      PMCID： PMC523272          DOI： 10.1128/JVI.78.21.11451-11460.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  145 in total

Review 1.  Mechanisms of cell transformation by papillomavirus E5 proteins.

Authors:  D DiMaio; D Mattoon
Journal:  Oncogene       Date:  2001-11-26       Impact factor: 9.867

2.  Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.

Authors:  William Alazawi; Mark Pett; Barbara Arch; Laurie Scott; Tom Freeman; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.

Authors:  E Berezutskaya; B Yu; A Morozov; P Raychaudhuri; S Bagchi
Journal:  Cell Growth Differ       Date:  1997-12

4.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 6.  Stem cells of the skin epithelium.

Authors:  Laura Alonso; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

7.  Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation.

Authors:  Alexandra Eichten; Debrah S Rud; Miranda Grace; Siribang-On Piboonniyom; Valerie Zacny; Karl Münger
Journal:  Virology       Date:  2004-02-05       Impact factor: 3.616

8.  A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina.

Authors:  Jens K Habermann; Kristina Hellman; Sandra Freitag; Kerstin Heselmeyer-Haddad; Ann-Cathrin Hellström; Keerti Shah; Gert Auer; Thomas Ried
Journal:  Cancer Genet Cytogenet       Date:  2004-01-01

Review 9.  Evolving views of telomerase and cancer.

Authors:  Maria A Blasco; William C Hahn
Journal:  Trends Cell Biol       Date:  2003-06       Impact factor: 20.808

10.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728
View more
  300 in total

1.  Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.

Authors:  Iris Cornet; Véronique Bouvard; Maria Saveria Campo; Miranda Thomas; Lawrence Banks; Lutz Gissmann; Jérôme Lamartine; Bakary S Sylla; Rosita Accardi; Massimo Tommasino
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

4.  Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3.

Authors:  Amy Baldwin; Dorre A Grueneberg; Karin Hellner; Jacqueline Sawyer; Miranda Grace; Wenliang Li; Ed Harlow; Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 5.  Human Papillomavirus Biology, Pathogenesis, and Potential for Drug Discovery: A Literature Review for HIV Nurse Clinical Scientists.

Authors:  Tara Walhart
Journal:  J Assoc Nurses AIDS Care       Date:  2015-07-08       Impact factor: 1.354

6.  Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.

Authors:  Enoc M Cortés-Malagón; José Bonilla-Delgado; José Díaz-Chávez; Alfredo Hidalgo-Miranda; Sandra Romero-Cordoba; Aykut Uren; Haydar Celik; Matthew McCormick; José A Munguía-Moreno; Eloisa Ibarra-Sierra; Jaime Escobar-Herrera; Paul F Lambert; Daniel Mendoza-Villanueva; Rosa M Bermudez-Cruz; Patricio Gariglio
Journal:  Virology       Date:  2013-09-27       Impact factor: 3.616

7.  Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600.

Authors:  Kyung-Won Huh; Joseph DeMasi; Hidesato Ogawa; Yoshihiro Nakatani; Peter M Howley; Karl Münger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

8.  Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.

Authors:  Zhenhua Lin; Martina Bazzaro; Mei-Cheng Wang; Kwun C Chan; Shiwen Peng; Richard B S Roden
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

9.  Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.

Authors:  Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto-Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

10.  Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.

Authors:  Kwang-Jin Oh; Anna Kalinina; Srilata Bagchi
Journal:  Virology       Date:  2009-11-10       Impact factor: 3.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.